13F Holdings
中文EN

THC TENET HEALTHCARE CORP

Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 70318 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.2%
TTM net income YoY114.1%
TTM EPS YoY133.1%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR83.5%

Margins

Gross margin—
Operating margin24.4%
Net margin13.1%
FCF margin15.0%
EBITDA margin28.4%

Returns

ROE61.3%
ROA9.5%
ROIC (approx.)28.2%
Asset turnover0.73x

Leverage & solvency

Liabilities / assets69.6%
Debt / equity2.43x
Current ratio1.58x
Interest coverage6.61x

Cash quality & payout

Operating cash flow / net income1.46x
Accruals ratio-4.4%
Payout ratio—
Capex / revenue4.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q3*2026-09-302026Q2*2026-06-302026Q1*2026-03-312025Q4*2025-12-312025Q3*2025-09-302025Q2*2025-06-302025Q1*2025-03-312024Q4*2024-12-31
Income statement
Revenue$5.63B$5.63B$5.37B$5.53B$5.29B$5.27B$5.22B$5.07B
Operating income$1.75B$1.50B$1.30B$853.00M$889.00M$823.00M$943.00M$821.00M
Interest expense$203.00M$204.00M$205.00M$205.00M$206.00M$206.00M$204.00M$203.00M
Pretax income—$1.34B$1.13B$681.00M$712.00M$642.00M$765.00M$655.00M
Income tax$360.00M$295.00M$226.00M$37.00M$133.00M$120.00M$143.00M$83.00M
Net income$1.00B$826.00M$702.00M$371.00M$342.00M$288.00M$406.00M$318.00M
EBITDA$1.97B$1.72B$1.52B$1.08B$1.11B$1.03B$1.15B$1.01B
EPS (basic)12.489.898.09—3.893.164.31—
EPS (diluted)12.419.848.01—3.863.144.27—
Weighted avg. shares (diluted)80.60M83.96M87.60M—88.61M91.79M95.02M—
Balance sheet
Cash & equivalents$2.67B$2.17B$2.97B$2.88B$2.98B$2.62B$3.00B$3.02B
Receivables$2.60B$2.61B$2.60B$2.56B$2.52B$2.53B$2.62B$2.54B
Inventory$340.00M$338.00M$343.00M$348.00M$346.00M$338.00M$344.00M$346.00M
Current assets$8.43B$7.83B$8.36B$7.85B$7.81B$7.30B$7.91B$7.68B
PP&E, net$6.29B$6.26B$6.25B$6.32B$6.09B$6.02B$5.99B$6.05B
Goodwill$11.64B$11.44B$11.39B$11.20B$11.16B$10.94B$10.79B$10.69B
Intangibles$1.23B$1.28B$1.32B$1.35B$1.35B$1.37B$1.40B$1.40B
Total assets$31.59B$30.68B$31.20B$29.68B$29.42B$28.70B$29.24B$28.94B
Current liabilities$5.32B$5.57B$6.15B$4.46B$4.56B$4.27B$4.45B$4.31B
Short-term debt$164.00M$160.00M$81.00M$79.00M$85.00M$84.00M$88.00M$92.00M
Long-term debt$13.08B$13.09B$13.13B$13.09B$13.10B$13.09B$13.08B$13.08B
Total debt$13.24B$13.25B$13.21B$13.17B$13.19B$13.18B$13.17B$13.17B
Total liabilities$22.00B$21.98B$22.35B$20.70B$20.72B$20.40B$20.58B$20.39B
Shareholders' equity$5.44B$4.66B$4.81B$4.22B$4.01B$3.75B$4.18B$4.17B
Net debt$10.57B$11.08B$10.24B$10.29B$10.21B$10.55B$10.17B$10.15B
Cash flow statement
Operating cash flow$1.28B$585.00M$1.64B$731.00M$1.06B$936.00M$815.00M-$331.00M
Capital expenditure$198.00M$168.00M$180.00M$364.00M$280.00M$193.00M$173.00M$330.00M
Free cash flow$1.08B$417.00M$1.46B$367.00M$778.00M$743.00M$642.00M-$661.00M
Investing cash flow-$298.00M-$203.00M-$317.00M-$389.00M-$385.00M-$314.00M-$187.00M-$372.00M
Financing cash flow-$479.00M-$1.18B-$1.24B-$434.00M-$323.00M-$996.00M-$648.00M-$372.00M
Depreciation & amortization$217.00M$215.00M$229.00M$231.00M$218.00M$208.00M$206.00M$193.00M
Stock-based compensation$35.00M$44.00M$25.00M$25.00M$38.00M$20.00M$21.00M$15.00M
Share buybacks$255.00M$1.04B$318.00M$198.00M$93.00M$747.00M$348.00M$0

Free plan shows the latest 8 periods; Pro shows all 70 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.